首页 | 本学科首页   官方微博 | 高级检索  
     


Risk Factors for and Time to Recurrence of Symptomatic Malignant Pleural Effusion in Patients With Metastatic Non-Small Cell Lung Cancer with EGFR or ALK Mutations
Authors:Audra J. Schwalk  David E. Ost  Sahara N. Saltijeral  Henriette De La Garza  Roberto F. Casal  Carlos A. Jimenez  Georgie A. Eapen  Jeff Lewis  Waree Rinsurongkawong  Vadeerat Rinsurongkawong  Jack Lee  Yasir Elamin  Jianjun Zhang  Jack A. Roth  Stephen Swisher  John V. Heymach  Horiana B. Grosu
Affiliation:1. Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX;2. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX;3. Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX;4. Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX;5. School of Medicine and Health Sciences TecSalud, Monterrey, Mexico
Abstract:
Keywords:lung cancer  pleural effusion  anaplastic lymphoma kinase  epidermal growth factor receptor  LDH"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  kwrd0055"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  lactate dehydrogenase  MPE"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  kwrd0065"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  malignant pleural effusion  NSCLC"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  kwrd0075"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  non-small cell lung cancer  SHR"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  kwrd0085"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  subdistribution hazard ratio  TKI"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  kwrd0095"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  tyrosine kinase inhibitor
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号